ResoTher Pharma and Queen Mary University London wins Translational Research grant from Barts Charity, UK
ResoTher Pharma and Professor Mauro Perretti, William Harvey Research Institute, Barts and [...]
ResoTher Pharma wins Innobooster award
ResoTher Pharma is pleased to announce that the company has been awarded [...]
ResoTher Pharma featured at StartUp Spotlight BioEurope Spring
ResoTher Pharma has been selected as one of the up-and-coming biotech companies [...]
Paul Hargreaves joins ResoTher Pharma as Chief Development Officer
ResoTher Pharma is pleased to announce that Paul Hargreaves, MSc, MBA will [...]
ResoTher Pharma profiled in MedWatch
Today ResoTher Pharma was profiled by the prominent Danish biotech publication MedWatch. [...]
ResoTher Pharma wins prestigious Merck Advance Biotech Grant Award
ResoTher Pharma is extremely pleased to announce our nomination as winner of [...]
ResoTher Pharma and Queen Mary University London wins Translational Research grant from Barts Charity, UK
ResoTher Pharma and Professor Mauro Perretti, William Harvey Research Institute, [...]
ResoTher Pharma wins Innobooster award
ResoTher Pharma is pleased to announce that the company has [...]
ResoTher Pharma featured at StartUp Spotlight BioEurope Spring
ResoTher Pharma has been selected as one of the up-and-coming [...]
Paul Hargreaves joins ResoTher Pharma as Chief Development Officer
ResoTher Pharma is pleased to announce that Paul Hargreaves, MSc, [...]
ResoTher Pharma profiled in MedWatch
Today ResoTher Pharma was profiled by the prominent Danish biotech [...]
ResoTher Pharma wins prestigious Merck Advance Biotech Grant Award
ResoTher Pharma is extremely pleased to announce our nomination as [...]
